Commercialization Alternatives In The New Medtech World
Executive Summary
In the current medtech environment, much attention is paid to evolving strategies to deal with the new challenges private companies are facing in areas like financing and regulatory, and a company’s sales strategy can be left for last or thought to be a topic for an acquirer. The authors describe the challenges that are emerging in the current medtech climate that make an early choice of a sales approach – from a variety of options – an important part of a company’s overall strategy. Not only can the choice of a viable commercialization strategy help drive revenue, it also can increase a company’s valuation at exit.